SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-062787
Filing Date
2024-05-17
Accepted
2024-05-17 08:26:06
Documents
1
Group Members
COSTAS CONSTANTINIDESIAN CHAROUBNEXTECH CROSSOVER I SCSPROCCO SGOBBO

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2414799d1_sc13g.htm SC 13G 109163
  Complete submission text file 0001104659-24-062787.txt   110919
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 24957784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748
Business Address 8 RUE LOU HEMMER SENNINGERBERG N4 L-1748 41.443666611
Nextech Crossover I GP S.a r.l. (Filed by) CIK: 0001916761 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G